Related Experiment Videos
Protein biotechnology: a BioUpdate Foundation post-experience course
1Department of Biomedical Sciences, University of Edinburgh, EH8 9XD, UK. Linda.Gilmore@ed.ac.uk
Expert Opinion on Investigational Drugs
|July 5, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Glycolysis as a target for the design of new anti-trypanosome drugs.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2001
Chitinases from Vibrio: activity screening and purification of chiA from Vibrio carchariae.
Journal of applied microbiology·2000
Polyanionic inhibitors of phosphoglycerate mutase: combined structural and biochemical analysis.
Journal of molecular biology·1999
Elezanumab for the treatment of spinal cord injury: assessing the clinical development journey to date.
Expert opinion on investigational drugs·2026
Advancements in longevity pharmacology research - are we finally seeing clinical progression?
Expert opinion on investigational drugs·2026
Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?
Expert opinion on investigational drugs·2026
Odronextamab: a bispecific antibody for follicular lymphoma.
Expert opinion on investigational drugs·2026
Evaluating the investigational drug landscape for ESR1-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.
Expert opinion on investigational drugs·2026
Darigabat and subtype-selective GABA-A modulation: pharmacology, clinical development, and translational challenges.
Expert opinion on investigational drugs·2026
Purification, Characterization, and Oil-Displacement Performance of Rhamnolipid Biosurfactant Produced by Bacillus sp. DQ-4.
Journal of microbiology and biotechnology·2026
Host cell protein profiling and immunogenicity assessment in E. coli-produced interferon beta.
Journal of pharmaceutical sciences·2026
Safety evaluation of an extension of use of the food enzyme bacillolysin from the non-genetically modified Bacillus amyloliquefaciens strain HPN 131.
EFSA journal. European Food Safety Authority·2026